MMP-2 [81], MMP-9 [82,83], and MMP-14 [84] are particularly implicated in BBB degradation in gliomas, where their activity weakens tight junctions between endothelial cells and facilitates tumor invasion into the brain parenchyma. This evidence concerns the gene MMP2 and central nervous system cancer.